BR112023025999A2 - Métodos de purificação de coluna de vetor de aav - Google Patents
Métodos de purificação de coluna de vetor de aavInfo
- Publication number
- BR112023025999A2 BR112023025999A2 BR112023025999A BR112023025999A BR112023025999A2 BR 112023025999 A2 BR112023025999 A2 BR 112023025999A2 BR 112023025999 A BR112023025999 A BR 112023025999A BR 112023025999 A BR112023025999 A BR 112023025999A BR 112023025999 A2 BR112023025999 A2 BR 112023025999A2
- Authority
- BR
- Brazil
- Prior art keywords
- aav vector
- column purification
- purification methods
- vector column
- complete
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000000746 purification Methods 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 4
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/422—Displacement mode
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209680P | 2021-06-11 | 2021-06-11 | |
| US202263366094P | 2022-06-09 | 2022-06-09 | |
| PCT/US2022/072859 WO2022261663A1 (en) | 2021-06-11 | 2022-06-10 | Aav vector column purification methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023025999A2 true BR112023025999A2 (pt) | 2024-02-27 |
Family
ID=84426294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023025999A BR112023025999A2 (pt) | 2021-06-11 | 2022-06-10 | Métodos de purificação de coluna de vetor de aav |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240271159A1 (https=) |
| EP (1) | EP4351755A4 (https=) |
| JP (1) | JP2024525142A (https=) |
| KR (1) | KR20240021231A (https=) |
| AU (1) | AU2022289035A1 (https=) |
| BR (1) | BR112023025999A2 (https=) |
| CA (1) | CA3221540A1 (https=) |
| CL (1) | CL2023003646A1 (https=) |
| CO (1) | CO2023018191A2 (https=) |
| IL (1) | IL309070A (https=) |
| MX (1) | MX2023014809A (https=) |
| PE (1) | PE20240359A1 (https=) |
| WO (1) | WO2022261663A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024036251A1 (en) * | 2022-08-12 | 2024-02-15 | Ultragenyx Pharmaceutical Inc. | Novel anion-exchange chromatography methods for separation of empty from full recombinant adeno-associated virus particles |
| EP4670812A1 (en) * | 2024-06-27 | 2025-12-31 | Sartorius Stedim Biotech GmbH | CONTINUOUS POLISHING OF VIRAL CAPSIDES |
| WO2026064763A1 (en) * | 2024-09-23 | 2026-03-26 | Regeneron Pharmaceuticals, Inc. | Partitioning anion exchange chromatography for purification of recombinant adeno-associated virus (raav) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004030327D1 (de) * | 2003-05-21 | 2011-01-13 | Genzyme Corp | Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind |
| US20120093775A1 (en) * | 2009-03-27 | 2012-04-19 | Proyecto De Biomedicina Cima, S.L. | Methods and compositions for the treatment of cirrhosis and liver fibrosis |
| MY207534A (en) * | 2017-06-30 | 2025-03-03 | Spark Therapeutics Inc | Aav vector column purification methods |
| US20230183659A1 (en) * | 2021-10-29 | 2023-06-15 | Homology Medicines, Inc. | Methods and compositions for the purification of adeno-associated virus |
| EP4602172A1 (en) * | 2022-10-11 | 2025-08-20 | MeiraGTx UK II Limited | Chromatography methods for purification of aav capsids |
-
2022
- 2022-06-10 EP EP22821261.9A patent/EP4351755A4/en active Pending
- 2022-06-10 US US18/568,530 patent/US20240271159A1/en active Pending
- 2022-06-10 MX MX2023014809A patent/MX2023014809A/es unknown
- 2022-06-10 WO PCT/US2022/072859 patent/WO2022261663A1/en not_active Ceased
- 2022-06-10 KR KR1020247000822A patent/KR20240021231A/ko active Pending
- 2022-06-10 PE PE2023003271A patent/PE20240359A1/es unknown
- 2022-06-10 CA CA3221540A patent/CA3221540A1/en active Pending
- 2022-06-10 BR BR112023025999A patent/BR112023025999A2/pt unknown
- 2022-06-10 IL IL309070A patent/IL309070A/en unknown
- 2022-06-10 JP JP2023576326A patent/JP2024525142A/ja active Pending
- 2022-06-10 AU AU2022289035A patent/AU2022289035A1/en active Pending
-
2023
- 2023-12-05 CL CL2023003646A patent/CL2023003646A1/es unknown
- 2023-12-21 CO CONC2023/0018191A patent/CO2023018191A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024525142A (ja) | 2024-07-10 |
| IL309070A (en) | 2024-02-01 |
| US20240271159A1 (en) | 2024-08-15 |
| CO2023018191A2 (es) | 2024-01-25 |
| WO2022261663A1 (en) | 2022-12-15 |
| EP4351755A4 (en) | 2025-04-23 |
| EP4351755A1 (en) | 2024-04-17 |
| AU2022289035A1 (en) | 2024-01-04 |
| PE20240359A1 (es) | 2024-02-27 |
| KR20240021231A (ko) | 2024-02-16 |
| CL2023003646A1 (es) | 2024-10-25 |
| CA3221540A1 (en) | 2022-12-15 |
| MX2023014809A (es) | 2024-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023025999A2 (pt) | Métodos de purificação de coluna de vetor de aav | |
| EP3712520B8 (en) | Air purifier, air purifying system | |
| WO2019241535A3 (en) | Anion exchange chromatography for recombinant aav production | |
| BRPI0508299A (pt) | sistema livre de produto animal e processo para purificação de uma toxina botulina | |
| EP4234688A3 (en) | Adeno-associated virus purification methods | |
| WO2013078170A8 (en) | Purification of anti-c-met antibodies | |
| MX2021008153A (es) | Sistemas y metodos para modular arn. | |
| NO20056211L (no) | Misbruksresistente amfetaminforbindelser | |
| BR112012014485A2 (pt) | processo contínuo para a carbonilação de etileno em uma fase líquida | |
| WO2010002428A3 (en) | Cyclosporin analogs and their use in the treatment of hcv infections | |
| BRPI0312521B8 (pt) | método para a separação de fibrinogênio de plasminogênio | |
| WO2019083318A3 (ko) | 개선된 면역글로불린의 정제방법 | |
| CY1115119T1 (el) | Αναστολεις μεταφορεα γλυκινης-1 | |
| MX2025006755A (es) | Regimenes de dosificacion de anticuerpos anti-calicreina plasmatica para el tratamiento de trastornos asociados a la calicreina plasmatica | |
| WO2021159129A3 (en) | Compositions and methods for circular rna expression | |
| MX2022007679A (es) | Composiciones purificadas de enterovirus y metodos de purificacion por cromatografia de afinidad con glutation. | |
| DE602006014009D1 (de) | Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs | |
| CY1117906T1 (el) | Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α | |
| BR112018074966A2 (pt) | anticorpos antagonísticos anti-molécula de orientação repulsiva a (grma) para tratar lesão na medula espinhal e dor | |
| BR0207447A (pt) | Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina | |
| BR0116704A (pt) | Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes | |
| GB0423196D0 (en) | Method | |
| MX2025004915A (es) | Ministrings de adn para producir virus adenoasociado | |
| BR112023024205A2 (pt) | Sistemas de produção do vetor viral, células modificadas para produção do vetor viral, e métodos de uso dos mesmos | |
| WO2023284806A9 (zh) | 特异性结合cd38、bcma和cd3的抗原结合分子及其医药用途 |